(Q38068107)

28 August 2017

1 reference

title

Progress on the research and development of human enterovirus 71 (EV71) vaccines (English)

1 reference

28 August 2017

Zhenglun Liang

1

1 reference

28 August 2017

Qunying Mao

series ordinal

2

1 reference

28 August 2017

Fan Gao

series ordinal

3

1 reference

28 August 2017

Junzhi Wang

series ordinal

4

1 reference

28 August 2017

publication date

17 December 2012

1 reference

28 August 2017

published in

Frontiers of medicine

1 reference

28 August 2017

volume

7

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

111-121

1 reference

https://scigraph.springernature.com/pub.10.1007/s11684-012-0237-z

28 August 2017

exact match

0 references

cites work

EV71: an emerging infectious disease vaccine target in the Far East?

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Development of enterovirus 71 vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Genetic evolution of enterovirus 71: epidemiological and pathological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

An apparently new enterovirus isolated from patients with disease of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Epidemic of hand, foot and mouth disease in West Bengal, India in August, 2007: a multicentric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Enterovirus 71 infection: An experience in Korea, 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Hand foot and mouth disease due to enterovirus 71 in Malaysia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Reemerging of enterovirus 71 in Taiwan: the age impact on disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Enterovirus 71 outbreak, Brunei

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Crystal Structure of Human Enterovirus 71

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Expression, purification and characterization of enterovirus-71 virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

DNA vaccine constructs against enterovirus 71 elicit immune response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children: an open label, phase 1 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

A murine oral enterovirus 71 infection model with central nervous system involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Scavenger receptor B2 is a cellular receptor for enterovirus 71

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Seroepidemiology of human enterovirus 71, Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Risk Factors of Enterovirus 71 Infection and Associated Hand, Foot, and Mouth Disease/Herpangina in Children During an Epidemic in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0237-Z

Changing epidemiology of hand, foot, and mouth disease in Hong Kong, 2001-2009.

21 January 2018

1 reference

12 December 2020

Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection

1 reference

12 December 2020

Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice

1 reference

12 December 2020

Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides

1 reference

12 December 2020

Dynamic change of mother-source neutralizing antibodies against enterovirus 71 and coxsackievirus A16 in infants.

1 reference

12 December 2020

Enterovirus 71 maternal antibodies in infants, Taiwan

1 reference

12 December 2020

Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process

1 reference

12 December 2020

Virological diagnosis of enterovirus type 71 infections: Experiences gained during an epidemic of acute CNS diseases in Hungary in 1978

1 reference

12 December 2020

Selection and characterization of vaccine strain for Enterovirus 71 vaccine development

1 reference

12 December 2020

Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71

1 reference

12 December 2020

Formaldehyde-inactivated human enterovirus 71 vaccine is compatible for co-immunization with a commercial pentavalent vaccine

1 reference

12 December 2020

Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection

1 reference

12 December 2020

Type I interferons protect mice against enterovirus 71 infection

1 reference

12 December 2020

10.1007/S11684-012-0237-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1047766174

0 references

1 reference